Sinopharm FY26 1H net profit rises 2.95% to RMB 5.34 billion; revenue increases 1.13% to RMB 286.04 billion
XLV•Cash flow and leverage
Operating cash outflow narrowed to RMB 23.76 billion from RMB 34.11 billion; gearing ratio edged up 0.66 percentage points to 66.29%.
Business segment performance
Pharmaceutical distribution revenue dipped 1.39% to RMB 215.5 billion, but operating profit climbed 7.75% to RMB 5.65 billion.
Retail pharmacy revenue increased 8.58% to RMB 18.64 billion; store count rose to 8,221 as of end-June from 7,975.
First-half revenue and profit
Sinopharm posted 2026 1H revenue of RMB 286.04 billion, up 1.13%, while net profit rose 2.95% to RMB 5.34 billion.
Attributable profit and margin
Net profit attributable to owners of the parent slipped 1.79% to RMB 3.4 billion; gross margin narrowed 0.37 percentage points to 6.74%.
